Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

NCT00554827

Conditions
Cutaneous T-Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +15 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford University School of Medicine Redwood City, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
View Trial Details
Completed

Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT01565668

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • UCLA School of Medicine Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View all 24 locations
View Trial Details
Completed

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

NCT01134341

Conditions
Cutaneous T-Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +17 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT01578707

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +27 more
Locations
  • Site #408 La Jolla, California, United States
  • Site #377 Los Angeles, California, United States
  • Site #403 Santa Maria, California, United States
  • Site #038 Stanford, California, United States
View all 76 locations
View Trial Details
Completed

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

NCT00722553

Conditions
Bladder Cancer, Bladder Neoplasm, Carcinoma, +20 more
Locations
  • The University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Peachtree Hematology/Oncology Consultants Atlanta, Georgia, United States
  • University of Rochester Cancer Center Rochester, New York, United States
  • University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States
View all 19 locations
View Trial Details

Related conditions